Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18837636 | 0.91 | EPHX1 (0.46) | ALDH1A1EPHX1LMNASMN1; SMN2HSD17B10 | |
| SCHEMBL18837599 | 0.91 | EPHX1 (0.46) | ALDH1A1EPHX1LMNASMN1; SMN2HSD17B10 | |
| SCHEMBL18837643 | 0.91 | EPHX1 (0.46) | ALDH1A1EPHX1LMNASMN1; SMN2HSD17B10 | |
| SCHEMBL18837634 | 0.91 | EPHX1 (0.46) | ALDH1A1EPHX1LMNASMN1; SMN2HSD17B10 | |
| SCHEMBL7003861 | 0.85 | — | — | |
| SCHEMBL9798469 | 0.83 | EPHX1 (0.45) | ALDH1A1EPHX1LMNASMN1; SMN2HSD17B10 | |
| SCHEMBL11361819 | 0.82 | EPHX1 (0.33) | ALDH1A1EPHX1LMNANOS3NOS1 | |
| SCHEMBL2252378 | 0.81 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL10628579 | 0.77 | EPHX1 (0.43) | EPHX1LMNASMN1; SMN2HSD17B10TSHR | |
| SCHEMBL15725508 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11053449-B2 | Thioether-containing phenolic compounds | THE LUBRIZOL CORPORATION (US) | 2021-07-06 | — | — | US | disclosed |
| EP-3374478-B1 | LUBRICATING COMPOSITION COMPRISING THIOETHER-SUBSTITUTED PHENOLIC COMPOUND | LUBRIZOL CORP (US) | 2021-01-06 | — | — | EP | disclosed |
| US-20200239805-A1 | THIOETHER-CONTAINING PHENOLIC COMPOUNDS | THE LUBRIZOL CORPORATION | 2020-07-30 | — | — | US | disclosed |
| EP-3374478-A1 | LUBRICATING COMPOSITION COMPRISING THIOETHER-SUBSTITUTED PHENOLIC COMPOUND | The Lubrizol Corporation (US) | 2018-09-19 | — | — | EP | disclosed |
| CN-108473899-A | Lubricating composition containing thioether-substituted phenol compound | 路博润公司 | 2018-08-31 | — | — | CN | disclosed |
| WO-2017083243-A1 | LUBRICATING COMPOSITION COMPRISING THIOETHER-SUBSTITUTED PHENOLIC COMPOUND | THE LUBRIZOL CORPORATION (US) | 2017-05-18 | — | — | WO | disclosed |
| US-6525000-B1 | N-aminoureas are reacted with formaldehyde to give methyleneimino ureas, cyclizing these to give tetrahydro-4H-1,3,4-oxa(or thia)diazines, and cyclizing the fused triazoles using phosgene; herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-25 | — | — | US | disclosed |
| EP-1095045-B1 | METHOD FOR PRODUCING ANELLATED TRIAZOLES AND NEW ANELLATED TRIAZOLES AND THEIR USE | BASF AG (DE) | 2003-01-15 | — | — | EP | disclosed |
| EP-0835248-B1 | 1-AMINO-3-BENZYLURACILS | BASF AG (DE) | 2001-02-21 | — | — | EP | disclosed |
| EP-0971904-A1 | NOVEL 1-AMINO-3 BENZYL URACILS | BASF AKTIENGESELLSCHAFT (DE) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998042682-A1 | NOVEL 1-AMINO-3 BENZYL URACILS | BASF AKTIENGESELLSCHAFT (DE) | 1998-10-01 | — | — | WO | disclosed |
| EP-0835248-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997001543-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11053449-B2 | Thioether-containing phenolic compounds | TST, TH, COMT | ALDH1A1 192/4885EPHX1 628/4885LMNA 4850/4885 |
| US-20200239805-A1 | THIOETHER-CONTAINING PHENOLIC COMPOUNDS | TST, TH, COMT | ALDH1A1 192/4885EPHX1 628/4885LMNA 4850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.